US Broker Ratings

Verona Pharma plc (VRNA) Stock Analysis: A Biotech Contender with Strong Sector Momentum

Verona Pharma plc (NASDAQ: VRNA), a promising player in the biotechnology sector, is making waves with its innovative approach to treating respiratory diseases. With a market..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 13.62% Upside Potential in the Biotech Sector

BeOne Medicines Ltd. (ONC) is capturing the attention of investors with its robust growth trajectory and innovative pipeline in the biotechnology sector. Based in Basel, Switzerland,..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 29% Upside Potential and Robust Dividend Yield

Merck & Company, Inc. (NYSE: MRK), a heavyweight in the healthcare sector, is drawing investors’ attention with its promising potential upside and solid dividend yield. With..

Chemed Corp (CHE) Stock Analysis: Unveiling a 25% Potential Upside for Investors

Chemed Corporation (NYSE: CHE), a stalwart in the healthcare sector, has long been a steady performer in the market with its dual-focused operations in hospice care..

Corcept Therapeutics (CORT) Investor Outlook: Exploring a Potential 61.26% Upside in the Biotech Sphere

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out as a beacon of innovation within the biotechnology sector, particularly with its focus on developing treatments for severe endocrinologic,..

Baxter International Inc. (BAX) Stock Analysis: Navigating the Challenges with a 30.72% Potential Upside

Investors keeping a close eye on Baxter International Inc. (NYSE: BAX) may find themselves at a crossroads as the company navigates a challenging financial landscape. With..

Encompass Health Corporation (EHC) Stock Analysis: A Look at Its 8.46% Upside Potential for Investors

For investors with a keen interest in the healthcare sector, Encompass Health Corporation (NYSE: EHC) presents a robust opportunity with a notable potential upside of 8.46%...

HCA Healthcare (HCA) Stock Analysis: Navigating Growth with a Robust $98 Billion Market Cap

HCA Healthcare, Inc. (NYSE: HCA), a titan in the healthcare sector, operates a vast network of hospitals and related healthcare entities across the United States. With..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 24.28% Upside Potential Amid Strategic Collaborations

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, is capturing investor attention with its robust portfolio focused on neurological and neurodegenerative diseases. As..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a High Valuation and Robust Revenue Growth

Medpace Holdings, Inc. (NASDAQ: MEDP) is a key player in the Healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of approximately..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Insights into Growth and Valuation

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the global pharmaceutical industry, presents an intriguing investment opportunity for those looking to diversify their portfolios..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Navigating High Dividend Yield Amidst Revenue Growth

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a stalwart in the healthcare and pharmaceutical retail sector, presents a complex picture to potential investors. With a rich history..

Revvity, Inc. (RVTY) Investor Outlook: 37.77% Potential Upside in the Diagnostics & Research Sector

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, is drawing significant attention from investors, particularly in the diagnostics and research industry. Founded in..

Insmed Incorporated (INSM) Stock Analysis: Unpacking the 16% Potential Upside

Insmed Incorporated (NASDAQ: INSM) stands out in the biotech sector with its focus on developing therapies for rare and serious diseases. As a prominent player in..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating a Potential 8.41% Upside in the Healthcare Sector

Universal Health Services, Inc. (NYSE: UHS) has emerged as a notable player in the healthcare sector, particularly within the medical care facilities industry. With its headquarters..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 10% Upside Potential in the Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a robust market capitalization..

Solventum Corporation (SOLV) Stock Analysis: Healthcare Innovator with a 20.85% Upside Potential

Solventum Corporation (NASDAQ: SOLV), a key player in the healthcare sector, has captured the attention of investors with a promising 20.85% potential upside, making it a..

The Cooper Companies, Inc. (COO) Stock Analysis: Unlocking a 25% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find The Cooper Companies, Inc. (NYSE: COO) an attractive proposition. With its expansive reach in the medical instruments..

Amgen Inc. (AMGN) Stock Analysis: Evaluating a 14.17% Potential Upside Amid Strong Dividend Yields

Amgen Inc. (AMGN), a titan in the healthcare sector, operates within the drug manufacturing industry, a realm known for its robust growth potential and constant innovation...

Cencora, Inc. (COR) Stock Analysis: Exploring the 8.42% Upside Potential and Robust Dividend Strategy

Cencora, Inc. (COR), formerly known as AmerisourceBergen Corporation, is a formidable player in the healthcare sector’s medical distribution industry. With a market capitalization of $59.52 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds